Now that Ebola is here, it has captured the attention it arguably deserved from us long ago. The latest news is that the patient first diagnosed in the U.S. is in critical condition, and receiving experimental therapy. Lapses in our public health system have been acknowledged, and a scramble to contain the damage, and prevent spread, are playing out as we look on, and worry.
That worry is home to both greater and lesser concerns. The lesser concerns are the more plausible. The patient in Dallas might have transmitted the disease. Others like him might find their way here. Our experimental therapies may fail.